Sensorion SA [ALSEN] vs Medincell S.A [MEDCL] Detailed Stock Comparison

Sensorion SA

EURONEXT
Loading...

Medincell S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Sensorion SA wins in 6 metrics, Medincell S.A. wins in 10 metrics, with 0 ties. Medincell S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sensorion SA Medincell S.A. Better
P/E Ratio (TTM) -3.79 -37.35 Sensorion SA
Price-to-Book Ratio 2.56 N/A N/A
Debt-to-Equity Ratio 2.77 -2.40 Sensorion SA
PEG Ratio -5.05 96.66 Medincell S.A.
EV/EBITDA -4.99 -85.82 Sensorion SA
Profit Margin (TTM) 0.00% -61.49% Sensorion SA
Operating Margin (TTM) -399.80% -46.74% Medincell S.A.
Return on Equity -50.47% 112.65% Medincell S.A.
Return on Assets (TTM) -26.12% -9.16% Medincell S.A.
Free Cash Flow (TTM) $-28.04M $17.81M Medincell S.A.
1-Year Return -38.10% 23.51% Medincell S.A.
Price-to-Sales Ratio (TTM) 33.50 26.03 Medincell S.A.
Enterprise Value $148.60M $821.18M Medincell S.A.
EV/Revenue Ratio 25.56 25.31 Medincell S.A.
Revenue per Share (TTM) $0 $1 Medincell S.A.
Earnings per Share (Diluted) $-0.10 $-0.61 Sensorion SA
Beta (Stock Volatility) 0.37 0.98 Sensorion SA

Sensorion SA vs Medincell S.A. Stock Performance Analysis

Loading Price Chart...

ALSEN
MEDCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sensorion SA-3.08%-32.43%-37.50%-63.24%-21.88%-26.47%
Medincell S.A.1.46%-0.86%1.61%25.88%25.88%25.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sensorion SA-38.10%-16.13%-87.19%-94.68%-94.29%-94.29%
Medincell S.A.23.51%23.51%23.51%23.51%23.51%23.51%

Performance & Financial Health Analysis: Sensorion SA vs Medincell S.A.

MetricALSENMEDCL
Market Information
Market Cap i€194.79M€831.60M
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,113,65692,952
90 Day Avg. Volume i4,040,55193,297
Last Close€0.25€27.82
52 Week Range€0.24 - €0.81€15.00 - €39.68
% from 52W High-68.81%-29.89%
All-Time High€19.90 (Jul 13, 2015)€39.68 (Oct 31, 2025)
% from All-Time High-98.74%-29.89%
Growth Metrics
Quarterly Revenue Growth0.05%0.50%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.00%-0.61%
Operating Margin (TTM) i-4.00%-0.47%
Return on Equity (TTM) i-0.50%1.13%
Debt to Equity (MRQ) i2.77-2.40
Cash & Liquidity
Book Value per Share (MRQ)€0.15€-0.93
Cash per Share (MRQ)€0.09€1.62
Operating Cash Flow (TTM) i€-27,279,000€-16,897,000
Levered Free Cash Flow (TTM) i€-17,371,500€-14,344,875
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Sensorion SA vs Medincell S.A.

MetricALSEN (Apr 26, 2026)MEDCL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-3.79-37.35
Forward P/E i-5.0596.66
PEG Ratio i-5.0596.66
Price to Sales (TTM) i33.5026.03
Price to Book (MRQ) i2.56N/A
Market Capitalization
Market Capitalization i€194.79M€831.60M
Enterprise Value i€148.60M€821.18M
Enterprise Value Metrics
Enterprise to Revenue i25.5625.31
Enterprise to EBITDA i-4.99-85.82
Risk & Other Metrics
Beta i0.370.98
Book Value per Share (MRQ) i€0.15€-0.93

Financial Statements Comparison: Sensorion SA vs Medincell S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALSEN (2025)MEDCL (2025)
Revenue/Sales i025.54M
Cost of Goods Sold iN/A0
COGS % of Revenue i-0.0%
Gross Profit iN/A25.54M
Gross Margin i-100.0%
Research & Development i28.84M24.31M
Operating Income (EBIT) i-30.75M-10.84M
Operating Margin i--42.4%
EBITDA i-28.96M-11.20M
EBITDA Margin i--43.9%
Pre-Tax Income i-29.43M-18.28M
Pre-Tax Income % of Revenue i--71.6%
Income Tax i4,000160,000
Income Tax % of Revenue i-0.6%
Net Income (Profit) i-29.43M-18.44M
Profit Margin i--72.2%

Balance Sheet & Liquidity Metrics

MetricALSEN (2025)MEDCL (2025)
Cash & Equivalents i47.46M59.04M
Total Current Assets i54.89M80.62M
Total Current Assets % of Revenue i-315.6%
Total Current Liabilities i11.97M29.87M
Total Current Liabilities % of Revenue i-117.0%
Long-Term Debt i124,00051.46M
Long-Term Debt % of Revenue i-201.5%
Total Shareholders Equity i44.48M-16.37M
Retained Earnings i-64.59M-18.44M
Retained Earnings % of Revenue i--72.2%
Property, Plant & Equipment i3.39M7.80M

Cash Flow Statement Comparison

MetricALSEN (2025)MEDCL (2025)
Operating Cash Flow i-27.87M14.12M
Operating Cash Flow % of Revenue i-55.3%
Capital Expenditures i-253,000-747,000
Free Cash Flow i-28.04M17.81M
FCF Margin i-69.7%
Debt Repayment i-846,000-4.11M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALSENMEDCL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i300.35M33.10M
Float Shares i300.41M30.23M
% Held by Insiders i34.81%35.05%
% Held by Institutions i35.01%30.34%
% Held by Public i30.18%34.61%

Dividend Analysis & Yield Comparison: Sensorion SA vs Medincell S.A.

MetricALSENMEDCL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A